Search research articles
Contact Us
Filters
Showing results (181-190 of 207) with videos related to
Page
of 21
Sort By:
The Journal of Urology
|
June 1, 1993
Mitomycin C in combination with orchiectomy for newly diagnosed metastatic prostate cancer: preliminary results on a randomized trial
H Van Poppel, F van den Broucke, J Derluyn, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 1, 1995
The status of bladder-preserving therapeutic strategies in the management of patients with muscle-invasive bladder cancer
K Koiso, W Shipley, F Keuppens, et al.
Clinical and Experimental Immunology
|
October 27, 1997
Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma
L E Van den Hove, S W Van Gool, H Van Poppel, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2014
Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients
F Moltzahn, J Karnes, P Gontero, et al.
Anticancer Research
|
September 3, 1999
Mitomycin C for metastatic prostate cancer: final analysis of a randomized trial
K Boel, H Van Poppel, H Goethuys, et al.
The Journal of Urology
|
October 12, 2000
Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup
P Iversen, C J Tyrrell, A V Kaisary, et al.
The Journal of Urology
|
August 1, 1995
Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group
H Van Poppel, D De Ridder, A A Elgamal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 26, 1999
The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer
M Debois, R Oyen, F Maes, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 1, 1988
Marked increase of Pseudomonas aeruginosa serotype 012 in Belgium since 1982
D Allemeersch, J Beumer, M Devleeschouwer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
June 26, 2013
Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?
L Van den Bergh, S Isebaert, M Koole, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 207) with videos related to
Sort By:
Page
of 21
The Journal of Urology
|
June 1, 1993
Mitomycin C in combination with orchiectomy for newly diagnosed metastatic prostate cancer: preliminary results on a randomized trial
H Van Poppel, F van den Broucke, J Derluyn, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 1, 1995
The status of bladder-preserving therapeutic strategies in the management of patients with muscle-invasive bladder cancer
K Koiso, W Shipley, F Keuppens, et al.
Clinical and Experimental Immunology
|
October 27, 1997
Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma
L E Van den Hove, S W Van Gool, H Van Poppel, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2014
Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients
F Moltzahn, J Karnes, P Gontero, et al.
Anticancer Research
|
September 3, 1999
Mitomycin C for metastatic prostate cancer: final analysis of a randomized trial
K Boel, H Van Poppel, H Goethuys, et al.
The Journal of Urology
|
October 12, 2000
Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup
P Iversen, C J Tyrrell, A V Kaisary, et al.
The Journal of Urology
|
August 1, 1995
Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group
H Van Poppel, D De Ridder, A A Elgamal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 26, 1999
The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer
M Debois, R Oyen, F Maes, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 1, 1988
Marked increase of Pseudomonas aeruginosa serotype 012 in Belgium since 1982
D Allemeersch, J Beumer, M Devleeschouwer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
June 26, 2013
Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?
L Van den Bergh, S Isebaert, M Koole, et al.
Page
of 21